Sort
82,697 grants matching “vaccine development”
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
$751,198Kathryn M Anastos · Albert Einstein College Of Medicine, Inc · U54 · FY2015 · CA
Contribution of anti-env immune responses to protection by live attenuated SIV
$751,187Ronald C Desrosiers · Harvard Medical School · P01 · FY2007 · AI
Building the foundations of commensal vaccines
$751,181Michael Andrew Fischbach · Stanford University · R01 · FY2024 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) clinical site protocols
$751,162Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2020 · AI
The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques
$751,157Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI
EARLY AND REINFECTION IN HIGH RISK WOMEN
$751,076Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R37 · FY2012 · AI
Toxoplasma Surface Antigens and Immunity
$751,025Michael Grigg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Neonatal Immunity to novel TF SHIVs
$751,002Wilton B Williams · Duke University · R01 · FY2022 · AI
Integrated Multi-omics of Melioidosis
$750,994Timothy Eoin West · University Of Washington · R01 · FY2018 · AI
SARS-CoV-2 protease inhibitors for treating COVID-19
$750,974Arun K Ghosh · Purdue University · R01 · FY2021 · AI
SARS-CoV-2 protease inhibitors for treating COVID-19
$750,974Arun K Ghosh · Purdue University · R01 · FY2025 · AI
SARS-CoV-2 protease inhibitors for treating COVID-19
$750,974Arun K Ghosh · Purdue University · R01 · FY2022 · AI
SARS-CoV-2 protease inhibitors for treating COVID-19
$750,974Arun K Ghosh · Purdue University · R01 · FY2023 · AI
Sleep and Vaccine Response in Nurses (SAV-RN)
$750,937Daniel J Taylor · University Of North Texas · R01 · FY2017 · AI
A T-independent pathway of B cell responses to oligomannosyl antigens of HIV-1
$750,916Denong Wang · Sri International · R56 · FY2013 · AI
Innate and early B cell responses to V. cholerae
$750,907Jason B Harris · Massachusetts General Hospital · R01 · FY2018 · AI
Modulation of Human Cells by Virulent Francisella tularensis
$750,874Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Baltimore Acute Hepatitis C Cooperative Center
$750,866Andrea L Cox · Johns Hopkins University · U19 · FY2014 · AI
Defining Protective CMV Immunity after Transplantation
$750,866Geoffrey Roger Hill · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
MAb Passive Vaccination against Acinetobacter baumannii
$750,854Brad J Spellberg · University Of Southern California · R01 · FY2022 · AI
Enrichment of the State-1 Conformation of the HIV-1 Envelope Glycoprotein
$750,826Joseph G Sodroski · Dana-Farber Cancer Inst · R01 · FY2021 · AI
Therapeutic targeting the host hypoxia-response pathway to treat Mucormycosis
$750,815Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2025 · AI
Influence of HIV infection on vaginal virome and risk of preterm birth in pregnant South African women
$750,682Heather Beryl Jaspan · Seattle Children'S Hospital · R01 · FY2022 · HD
Transforming Clinical and Translational Research and Education at Rockefeller
$750,638Barry Coller · Rockefeller University · UL1 · FY2009 · RR
Dissecting the pathogenesis of HIV-TB Immune reconstitution inflammatory syndrome
$750,630Philana Ling Lin · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI